Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Albertsons Seeks $9.3 Billion From Kroger Over Failed Merger
Orsted to Take Full Ownership of UK Offshore Wind Farm for £15 Million
European Auto Stocks Rise as EU-China Trade Deal Targets Hybrid Imports
Elon Musk Donates $366 Million to 2026 US Midterms
INWIT Shareholders Explore $7.1 Billion Take-Private Deal
Moonshot AI Executives Seek Settlement Ahead of Hong Kong IPO
Apple Supplier Luxshare Faces US Patent Probe, Sees Limited Impact
Amazon in Talks to Acquire AI Startup Decart for $7 Billion
Hong Kong’s Second Solana ETF Launches With Lower Fees
Airbus Tests Valkyrie Combat Drone in Europe for Eurofighter Integration
Yandex Data Center Hit by Drone Strike as Russia-Ukraine Cyber Infrastructure Attacks Escalate
FAA Warns US Airlines Over Saudi Arabia Flight Risks
Arthur Hayes Announces FLOP Testnet Launch Within Weeks
Morgan Stanley Predicts $10 Trillion RWA Market by 2030
Bumble Shares Surge 50% on $1 Billion Buyout Talks
Nasdaq Faces Pullback to 26,225 Despite Bullish Outlook, UBS Says
Canton Network Expands in South Korea With Major Partnerships 



